Site is loading…
Dana-Farber Cancer Institute/Boston Children's Hospital is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.
Dana-Farber Cancer Institute/Boston Children's Hospital has participated in 8 clinical trials with 4 currently active.
Therapeutic areas: Hematopoietic Stem Cell Transplant (HSCT), Diffuse Alveolar Hemorrhage, Thrombotic Microangiopathies.
Sponsors: Children's Hospital Medical Center, Cincinnati, Children's Hospital of Philadelphia, Gilead Sciences.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Boston
Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber Cancer Institute/Boston Children's Hospital has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber Cancer Institute/Boston Children's Hospital has 8 clinical trials on record, with 4 currently active. Their work covers Hematopoietic Stem Cell Transplant (HSCT), Diffuse Alveolar Hemorrhage, Thrombotic Microangiopathies.
Dana-Farber Cancer Institute/Boston Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.